Representatives of a data center that opened in East Vineland in 2025 have scheduled an event to answer questions and address ...

Learn Microsoft Copilot basics, free and paid differences, and prompt tips to draft Outlook replies faster and summarize ...

Professionals worldwide gain standardized recognition for web development skills through assessment-based certification ...

eHealth Africa Academy has graduated 92 students across Nigeria and Africa, building their capacities in advanced javascript and data analytics. The organisation said this was part of its goal to ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Vivek Yadav, an engineering manager from ...

A vulnerability in the ‘node-forge’ package, a popular JavaScript cryptography library, could be exploited to bypass signature verifications by crafting data that appears valid. The flaw is tracked as ...

Vepdegestrant is an investigational, orally bioavailable PROTAC estrogen receptor degrader. In the VERITAC-2 Phase 3 study, vepdegestrant demonstrated statistically significant and clinically ...

Good morning, and welcome to the Transgene conference call. [Operator Instructions] As a reminder, this call is being recorded, and a replay will be made available on the Transgene website following ...

PE giant Vista Equity Partners plans to reduce staff head count as it adopts artificial intelligence tools across its firm and portfolio, a move that highlights tensions between efficiency drives and ...

Please provide your email address to receive an email when new articles are posted on . More patients with end-stage renal disease on dialysis vs. patients without kidney disease had comorbidities.

Orum Therapeutics (“Orum” or the “Company”) (KRX: 475830), a public biotechnology company pioneering the field of degrader-antibody conjugates (DACs), today announced that preclinical data for ...

Please provide your email address to receive an email when new articles are posted on . Speakers issued an overview of 20 years of cardiometabolic disease management. Certain therapies changed ...